medigraphic.com
Anales de Otorrinolaringología Mexicana

2022, Number 1

<< Back Next >>

Otorrinolaringología 2022; 67 (1)

Otological manifestations of patients with granulomatosis with poliangeitis in a high specialty medical unit

Flores-Meza B, González-Armas JA, Piña-Uribe G, Bustamante-González R

Language: Spanish
References: 23
Page: 73-81
PDF size: 236.06 Kb.


ABSTRACT

Objective: To determine the otological manifestations of patients with granulomatosis with polyangiitis.
Materials and Methods: A descriptive, cross-sectional, analytical and observational study of the otological, nose and throat manifestations in patients with granulomatosis with polyangiitis, done from July to November 2019 at National Medical Center La Raza, Mexico City.
Results: Twenty patients with the diagnosis of granulomatosis with polyangiitis, 12 women and 8 men, mean age of 53 years, were evaluated. Otological manifestations were: aural fullness (14/20), tinnitus (12/20) and hearing loss (11/20).
Conclusions: Average age of granulomatosis with polyangiitis involvement was the fifth decade of life, predominantly in women, all patients presented otorhinolaryngological manifestations, highlighting different degrees of hearing loss in half of the population. There are significant associations of inner and middle ear manifestations. The complete otorhinolaryngological examination is important for the control and limitation of sequelae produced by this disease.


REFERENCES

  1. Bosch J, Ma C, Cid R, Solas R, Selva A, Cervera R. Vasculitis. En: Farreras V, Rozman C, editores. Medicina interna. 2012; 1032-1048.

  2. Bongu Grygiel-Górniak, Nattakarn Limphaibool, Katarzyna Perkowska, Mariusz Puszczewicz. Clinical manifestations of granulomatosis with polyangiitis: key considerations and major features. Postgraduate Medicine 2018; 130 (7): 581-596. Disponible en: https://doi.org/10.1080/003254 81.2018.1503920.

  3. Comarmond C, Cacoub P. Granulomatosis with polyangiitis (Wegener): Clinical aspects and treatment. Autoinmmun Rev 2014; 13 (11): 1121-1125. doi: 10.1016/j. autrev.2014.08.017.

  4. Mohammad AJ, Jacobsson LTH, Mahr AD, Sturfelt G, Segelmark M. Prevalence of Wegener’s granulomatosis, microscopic polyangiitis, polyarteritis nodosa and churgstrauss syndrome within a defined population in southern sweden. Rheumatology (Oxfrod) 2007; 46: 1329-1337. doi: 10.1093/rheumatology/kem107

  5. Kobayashi S, Fujimoto S. Epidemiology of vasculitides: differences between Japan, Europe and North America. Clin Exp Nephrol 2013; 17: 611-614. doi: 10.1007/s10157- 013-0813-9.

  6. Rasmussen N. Management of the ear, nose and throat manifestations of Wegener granulomatosis: an otorhinolaryngologist’s perspective. Curr Opin Rheumatol 2001; 13 (1): 3-11. doi: 10.1097/00002281-200101000- 00002.

  7. Yi ES, Colby TV. Wegener’s granulomatosis. Semin Diagn Pathol 2001; 18 (1): 34-46.

  8. Gubbels S, Barkhuizen A, Hwang P. Head and neck manifestations of Wegener's granulomatosis. Otolaryngol Clin North Am 2003; 36 (4): 685-705.

  9. Lyons PA, Rayner TF, Trivedi S, Holle J, et al. Genetically distinct subsets within ANCA associated vasculitis. N Engl J Med 2012; 367: 214-223. DOI: 10.1056/NEJMoa1108735.

  10. Greco A, Marinelli C, Fusconi M, Macri G, Gallo A, De Virgilio A et al. Clinic manifestations in granulomatosis with polyangiitis. Int J Immunopathol Pharmacol 2015; 29 (2): 151-159. doi: 10.1177/0394632015617063.

  11. Lutalo P, D’Cruz D. Diagnosis and classification of granulomatosis with polyangiitis (aka Wegener’s granulomatosis). J Autoimmun 2014; 48 (1): 94-98. doi: 10.1016/j. jaut.2014.01.028.

  12. Takagi D, Nakamaru Y, Maguchi S, Furuta Y, Fukuda S. Otologic manifestations of Wegener’s granulomatosis. Laryngoscope 2002; 112 (9): 1684-1690. doi: 10.1097/00005537- 200209000-00029.

  13. Mahr A, Neogi T, Lavalley M, Davis J, Hoffman G, Mccune W, et al. Assessment of the item selection and weighting in the Birmingham Vasculitis Activity Score for Wegener’s granulomatosis. Arthritis Rheum 2008; 59 (6): 884-891. https://dx.doi.org/10.1002%2Fart.23707.

  14. Cartin-Ceba R, Peikert T, Specks U. Pathogenesis ANCA associated vasculitis. Curr Rheumatol Rep 2012; 14 (6): 481-493. doi: 10.1007/s11926-012-0286-y.

  15. Koldingsnes W, Nossent J. Baseline features and initial treatment as predictors of remission and relapse in Wegener’s granulomatosis. J Rheumatol 2003; 30 (1): 80-88.

  16. Weiner M, Mein S, Mohammad AJ, Hruskova Z, Tanna A, Bruchfeld A et al. Outcome and treatment of elderly patients with ANCA-associated vasculitis. Clin J Am Soc Nephrol 2015; 10 (7): 1128-1135. doi: 10.2215/CJN.00480115.

  17. Kamali S, Erer B, Artim-Esen B, Gul A, Ocal L, Konice M et al. Predictors of damage and survival in patients with Wegener’s granulomatosis: Analysis of 50 patients. J Rheumatol 2010; 37 (2): 374-378. doi: 10.3899/jrheum.090387.

  18. Marian V, Gnadhi A, Newlands S. Rheumatologic, granulomatous, and other systemic diseases affecting the head and neck. En: Johnson J, Rosen C, editores. Bailey’s Head and Neck Surgery. Philadelphia: Wolters Kluwer, 2014; 267-295.

  19. Lagos A, Heider C, Araya M, San Martín J. Estenosis subglótica en pacientes con granulomatosis con poliangeítis. Rev Otorrinolaringol Cir Cabeza Cuello 2016; 76 (2): 184-192.

  20. McCaffrey T, McDonald T, Facer G, DeRemee R. Otologic manifestations of Wegener’s granulomatosis. Otolaryngol Head Neck Surg 1980; 88 (5): 586-593. https://doi.org/10. 1177%2F019459988008800512.

  21. Wierzbicka M, Szyfter W, Puszczewicz M, Borucki L, Bartochowska A. Otologic symptoms as initial manifestation of Wegener granulomatosis: Diagnostic dilemma. Otol Neurotol 2011; 32: 996-1000. doi: 10.1097/MAO.0b013e31822558fd.

  22. Yegin E, Can M, Yilmaz N, Aydin S, Yavuz S, Tuglular S, et al. Activity and damage in granulomatosis with polyangiits. Int J Rheum Dis 2013; 16 (1): 61-71. doi: 10.1111/1756- 185x.12022.

  23. Cañas C, Jiménez C, Restrepo J, Rondón F, Peña M, Rojas C, et al. Evaluación de la actividad de las vasculitis. AMC 1998; 23 (4): 162-174.




2020     |     www.medigraphic.com